These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26558526)

  • 21. Survival after liver resection for metastatic colorectal carcinoma in a large population.
    Shah SA; Bromberg R; Coates A; Rempel E; Simunovic M; Gallinger S
    J Am Coll Surg; 2007 Nov; 205(5):676-83. PubMed ID: 17964443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determinants of survival after liver resection for metastatic colorectal carcinoma.
    Parau A; Todor N; Vlad L
    J BUON; 2015; 20(1):68-77. PubMed ID: 25778299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aggressive surgery in the multimodality treatment of liver metastases from colorectal cancer.
    Belev N; Takorov I; Dimov P; Vladov N; Penov V
    J BUON; 2007; 12(2):209-13. PubMed ID: 17600874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is adjuvant therapy with streptozotocin and 5-fluorouracil useful after resection of liver metastases from digestive endocrine tumors?
    Maire F; Hammel P; Kianmanesh R; Hentic O; Couvelard A; Rebours V; Zappa M; Raymond E; Sauvanet A; Louvet C; Lévy P; Belghiti J; Ruszniewski P
    Surgery; 2009 Jan; 145(1):69-75. PubMed ID: 19081477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perioperative complications after hepatectomy with or without intra-arterial chemotherapy for bilobar colorectal cancer liver metastases.
    Tanaka K; Shimada H; Ueda M; Matsuo K; Endo I; Sekido H; Togo S
    Surgery; 2006 May; 139(5):599-607. PubMed ID: 16701091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival outcome of re-resection for recurrent liver metastases of colorectal cancer: a retrospective study.
    Chok KS; Cheung TT; Chan AC; Dai WC; Chan SC; Fan ST; Poon RT; Lo CM
    ANZ J Surg; 2014; 84(7-8):545-9. PubMed ID: 23809019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is complete liver resection without resection of synchronous lung metastases justified?
    Mise Y; Kopetz S; Mehran RJ; Aloia TA; Conrad C; Brudvik KW; Taggart MW; Vauthey JN
    Ann Surg Oncol; 2015 May; 22(5):1585-92. PubMed ID: 25373535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival after hepatic resection in metastatic colorectal cancer: a population-based study.
    Cummings LC; Payes JD; Cooper GS
    Cancer; 2007 Feb; 109(4):718-26. PubMed ID: 17238180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver surgery for colorectal metastases: results after 10 years of follow-up. Long-term survivors, late recurrences, and prognostic role of morbidity.
    Viganò L; Ferrero A; Lo Tesoriere R; Capussotti L
    Ann Surg Oncol; 2008 Sep; 15(9):2458-64. PubMed ID: 18463927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Longterm results and prognostic indicators after cryotherapy and hepatic arterial chemotherapy with or without resection for colorectal liver metastases in 224 patients: longterm survival can be achieved in patients with multiple bilateral liver metastases.
    Yan TD; Padang R; Morris DL
    J Am Coll Surg; 2006 Jan; 202(1):100-11. PubMed ID: 16377503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infarct-like necrosis: a distinct form of necrosis seen in colorectal carcinoma liver metastases treated with perioperative chemotherapy.
    Chang HH; Leeper WR; Chan G; Quan D; Driman DK
    Am J Surg Pathol; 2012 Apr; 36(4):570-6. PubMed ID: 22301494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Up-front hepatic resection for metastatic colorectal cancer results in favorable long-term survival.
    Nanji S; Cleary S; Ryan P; Guindi M; Selvarajah S; Al-Ali H; Grieg P; McGilvary I; Taylor B; Wei A; Moulton CA; Gallinger S
    Ann Surg Oncol; 2013 Jan; 20(1):295-304. PubMed ID: 23054102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
    John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
    Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sinusoidal obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy.
    Tamandl D; Klinger M; Eipeldauer S; Herberger B; Kaczirek K; Gruenberger B; Gruenberger T
    Ann Surg Oncol; 2011 Feb; 18(2):421-30. PubMed ID: 20844968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Large variation in the utilization of liver resections in stage IV colorectal cancer patients with metastases confined to the liver.
    't Lam-Boer J; Al Ali C; Verhoeven RH; Roumen RM; Lemmens VE; Rijken AM; De Wilt JH
    Eur J Surg Oncol; 2015 Sep; 41(9):1217-25. PubMed ID: 26095702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness and cost-effectiveness of peri-operative versus post-operative chemotherapy for resectable colorectal liver metastases.
    Ercolani G; Cucchetti A; Cescon M; Peri E; Brandi G; Del Gaudio M; Ravaioli M; Zanello M; Pinna AD
    Eur J Cancer; 2011 Oct; 47(15):2291-8. PubMed ID: 21652204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perioperative chemotherapy and liver resection for hepatic metastases of colorectal cancer.
    Hasegawa K; Takahashi M; Ohba M; Kaneko J; Aoki T; Sakamoto Y; Sugawara Y; Kokudo N
    J Hepatobiliary Pancreat Sci; 2012 Sep; 19(5):503-8. PubMed ID: 22426591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reappraisal of the risks and benefits of major liver resection in patients with initially unresectable colorectal liver metastases.
    Cauchy F; Aussilhou B; Dokmak S; Fuks D; Gaujoux S; Farges O; Faivre S; Lepillé D; Belghiti J
    Ann Surg; 2012 Nov; 256(5):746-52; discussion 752-4. PubMed ID: 23095618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving treatment and survival: a population-based study of current outcomes after a hepatic resection in patients with metastatic colorectal cancer.
    Zaydfudim VM; McMurry TL; Harrigan AM; Friel CM; Stukenborg GJ; Bauer TW; Adams RB; Hedrick TL
    HPB (Oxford); 2015 Nov; 17(11):1019-24. PubMed ID: 26353888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving the clinical risk score: an analysis of molecular biomarkers in the era of modern chemotherapy for resectable hepatic colorectal cancer metastases.
    Maithel SK; Gönen M; Ito H; Dematteo RP; Allen PJ; Fong Y; Blumgart LH; Jarnagin WR; D'Angelica MI
    Surgery; 2012 Feb; 151(2):162-70. PubMed ID: 21982065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.